Orange Book product · Generic (ANDA)
CALCIPOTRIENE
CALCIPOTRIENE
At a glance
Dec 26, 2017
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 26, 2017
8 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
CALCIPOTRIENE
Strength
0.005%
Dosage form
SOLUTION
Route
TOPICAL
TE code
AT
Application
ANDA 207163
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CALCIPOTRIENE
- 2010SORILUXBrand (NDA)
NDA 022563 · MAYNE PHARMA
- 1997DOVONEXBrand (NDA)
NDA 020611 · LEO PHARM
- 1996DOVONEXBrand (NDA)
NDA 020554 · LEO PHARMA AS
- 1993DOVONEXBrand (NDA)
NDA 020273 · LEO PHARMA AS
- 2015CALCIPOTRIENEGeneric (ANDA)
ANDA 205772 · GLENMARK SPECLT
- 2012CALCIPOTRIENEGeneric (ANDA)
ANDA 200935 · CHARTWELL RX
- 2011CALCIPOTRIENEGeneric (ANDA)
ANDA 078468 · COSETTE PHARMS NC
- 2010CALCIPOTRIENEGeneric (ANDA)
ANDA 090633 · GLENMARK PHARMS
- 2009CALCIPOTRIENEGeneric (ANDA)
ANDA 077029 · CHARTWELL RX
- 2009CALCIPOTRIENEGeneric (ANDA)
ANDA 077579 · HIKMA
- 2008CALCIPOTRIENEGeneric (ANDA)
ANDA 078305 · FOUGERA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
